1-Methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione
95%
- Product Code: 210020
CAS:
5401-15-0
| Molecular Weight: | 166.14 g./mol | Molecular Formula: | C₆H₆N₄O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD14756264 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, dry, sealed |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly kinase inhibitors. It serves in the development of targeted cancer therapies due to its structural similarity to purine bases, allowing it to interact with ATP-binding sites in enzymes. Commonly employed in medicinal chemistry for optimizing drug candidates with improved selectivity and metabolic stability. Also utilized in research settings for designing novel bioactive molecules with potential antiviral and anti-inflammatory properties.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1g | 10-20 days | ฿19,460.00 |
+
-
|
1-Methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly kinase inhibitors. It serves in the development of targeted cancer therapies due to its structural similarity to purine bases, allowing it to interact with ATP-binding sites in enzymes. Commonly employed in medicinal chemistry for optimizing drug candidates with improved selectivity and metabolic stability. Also utilized in research settings for designing novel bioactive molecules with potential antiviral and anti-inflammatory properties.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :